Altered dendritic cell-natural killer interaction in Kenyan sex workers resistant to HIV-1 infection

AIDS

Volumn 26, Issue 4, 2012, Pages 429-436

  Ghadially, Hormas ^a,b   Keynan, Yoav ^c,d   Kimani, Joshua ^c,d   Kimani, Makobu ^d   Ball, T Blake ^c,d,e   Plummer, Francis A ^c,d,f   Mandelboim, Ofer ^a   Meyers, Adrienne F A ^c,d,e  

^a HEBREW UNIVERSITY   (Israel)

^b MEDIMMUNE   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF NAIROBI   (Kenya)

^e PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^f PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

dendritic cells; HIV; immunology; natural killer cells; resistance to HIV

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; CELL PROTEIN; DNAM 1 PROTEIN; GAMMA INTERFERON; INTERLEUKIN 12; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D; UNCLASSIFIED DRUG;

ARTICLE; CELL INTERACTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KENYA; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROSTITUTION; PROTEIN EXPRESSION; VIRUS LOAD;

ADULT; ANTIGENS, CD3; ANTIGENS, CD56; CELLS, CULTURED; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV ANTIBODIES; HIV SERONEGATIVITY; HIV-1; HUMANS; IMMUNITY, INNATE; IMMUNOPHENOTYPING; KENYA; KILLER CELLS, NATURAL; OCCUPATIONAL EXPOSURE; SEX WORKERS;

EID: 84857040282     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834f98ea     Document Type: Article

References (42)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47:187-376. (Pubitemid 20010960)
2. Moretta L, Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 2004; 23:255-259. (Pubitemid 38294490)
3. Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986; 319:675-678. (Pubitemid 16119452)
4. Mistry AR, O'Callaghan CA. Regulation of ligands for the activating receptor NKG2D. Immunology 2007; 121:439-447. (Pubitemid 47030096)
5. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002; 296:1323-1326. (Pubitemid 34522789)
6. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, Naidenko OV, et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 2002; 99:8826-8831. (Pubitemid 34693643)
7. Arnon TI, Achdout H, Lieberman N,Gazit R,Gonen-Gross T, Katz G, et al. The mechanisms controlling the recognition of tumorand virus-infected cells by NKp46. Blood 2004; 103:664-672. (Pubitemid 38140102)
8. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001; 409:1055-1060. (Pubitemid 32204059)
9. Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol 2005; 6:515-523. (Pubitemid 41716765)
10. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L. What is a natural killer cell? Nat Immunol 2002; 3:6-8. (Pubitemid 34065607)
11. Reading PC, Whitney PG, Barr DP, Smyth MJ, Brooks AG. NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection. Eur J Immunol 2006; 36:897-905.
12. Wabuke-Bunoti MA, Bennink JR, Plotkin SA. Influenza virusinduced encephalopathy in mice: interferon production and natural killer cell activity during acute infection. J Virol 1986; 60:1062-1067. (Pubitemid 17179283)
13. Lee SH, Girard S, Macina D, Busa M, Zafer A, Belouchi A, et al. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 2001; 28:42-45. (Pubitemid 32405814)
14. Brenner BG, Dascal A, Margolese RG, Wainberg MA. Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases. J Leukoc Biol 1989; 46:75-83. (Pubitemid 19176602)
15. Alter G, Teigen N, Davis BT, Addo MM, Suscovich TJ, Waring MT, et al. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 2005; 106:3366-3369. (Pubitemid 41609166)
16. Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, Marcenaro E, et al. Characterization of CD56-/CD16R natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci USA 2005; 102:2886-2891. (Pubitemid 40299886)
17. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002; 31:429-434. (Pubitemid 35154456)
18. Ravet S, Scott-Algara D, Bonnet E, Tran HK, Tran T, Nguyen N, et al. Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood 2007; 109:4296-4305. (Pubitemid 46743396)
19. Nolting A, Dugast AS, Rihn S, Luteijn R, Carrington MF, Kane K, et al. MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction. Virology 406:12-20.
20. Vitale M, Della Chiesa M, Carlomagno S, Pende D, Arico M, Moretta L,Moretta A. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 2005; 106:566-571. (Pubitemid 40981252)
21. Koka R, Burkett P, Chien M, Chai S, Boone DL, Ma A. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells. J Immunol 2004; 173:3594-3598. (Pubitemid 39280717)
22. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007; 26:503-517. (Pubitemid 46602996)
23. Spaggiari GM, Carosio R, Pende D, Marcenaro S, Rivera P, Zocchi MR, et al. NK cell-mediated lysis of autologous antigenpresenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur J Immunol 2001; 31:1656-1665. (Pubitemid 32547327)
24. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002; 195:343-351. (Pubitemid 34461492)
25. Ferlazzo G, Semino C, Melioli G. HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunol Lett 2001; 76:37-41. (Pubitemid 32166909)
26. Andrews DM, Andoniou CE, Granucci F, Ricciardi-Castagnoli P, Degli-Esposti MA. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol 2001; 2:1077-1084. (Pubitemid 33069504)
27. Andrews DM, Scalzo AA, Yokoyama WM, Smyth MJ, Degli-Esposti MA. Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol 2003; 4:175-181. (Pubitemid 36193020)
28. Andoniou CE, van Dommelen SL, Voigt V, Andrews DM, Brizard G, Asselin-Paturel C, et al. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 2005; 6:1011-1019. (Pubitemid 41486186)
29. Altfeld M, Fadda L, Frleta D, Bhardwaj N. DCs and NK cells: critical effectors in the immune response to HIV-1. Nat Rev Immunol 11:176-186.
30. Alter G, Altfeld M. Mutiny or scrutiny: NK cell modulation of DC function in HIV-1 infection. Trends Immunol 32:219-224.
31. Mavilio D, Lombardo G, Kinter A, Fogli M, La Sala A, Ortolano S, et al. Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med 2006; 203:2339-2350. (Pubitemid 44498368)
32. Melki MT, Saidi H, Dufour A, Olivo-Marin JC, Gougeon ML. Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk-a pivotal role of HMGB1. PLoS Pathog 6:e1000862.
33. Alter G, Kavanagh D, Rihn S, Luteijn R, Brooks D, Oldstone M, et al. IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection. J Clin Invest 120:1905-1913.
34. Meyers AF, Fowke KR. International symposium on natural immunity to HIV: a gathering of the HIV-exposed seronegative clan. J Infect Dis 202(Suppl 3):S327-S328.
35. Fowke KR, Nagelkerke NJ, Kimani J, Simonsen JN, Anzala AO, Bwayo JJ, et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996; 348:1347-1351. (Pubitemid 26383775)
36. Fowke KR, Dong T, Rowland-Jones SL, Oyugi J, Rutherford WJ, Kimani J, et al. HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production. AIDS Res Hum Retroviruses 1998; 14:1521-1530. (Pubitemid 28527796)
37. Simonsen JN, Plummer FA, Ngugi EN, Black C, Kreiss JK, Gakinya MN, et al. HIV infection among lower socioeconomic strata prostitutes in Nairobi. AIDS 1990; 4:139-144. (Pubitemid 20108772)
38. Plummer FA, Simonsen JN, Cameron DW, Ndinya-Achola JO, Kreiss JK, Gakinya MN, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991; 163:233-239.
39. Tasca S, Tambussi G, Nozza S, Capiluppi B, Zocchi MR, Soldini L, et al. Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis. AIDS 2003; 17:2291-2298. (Pubitemid 38147014)
40. Brandt CS, Baratin M, Yi EC, Kennedy J, Gao Z, Fox B, et al. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med 2009; 206:1495-1503.
41. Sivori S, Pende D, Bottino C, Marcenaro E, Pessino A, Biassoni R, et al. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol 1999; 29:1656-1666. (Pubitemid 29224471)
42. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-252. (Pubitemid 28155090)